Current Income Tax Expense (Benefit) of CRESCENT BIOPHARMA, INC. from 31 Mar 2016 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
CRESCENT BIOPHARMA, INC. quarterly and annual Current Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2016 to 31 Mar 2025.
  • CRESCENT BIOPHARMA, INC. Current Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $0.
Source SEC data
View on sec.gov
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), Annual (USD)

CRESCENT BIOPHARMA, INC. Quarterly Current Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q1 2019 $0 $0 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q1 2018 $0 $0 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $0 $0 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1

CRESCENT BIOPHARMA, INC. Annual Current Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2020 $0 01 Jan 2020 31 Dec 2020 10-Q 03 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.